Back to Authors

Chen, Chien

https://orcid.org/0000-0002-8406-9659

Mayo Clinic

University of Arkansas for Medical Sciences

Citations 1

FDG‐PET/CT and Pathology in Newly Diagnosed Head and Neck Cancer: ACRIN 6685 Trial, FDG‐PET/CT cN0
Stack, Brendan C. , Duan, Fenghai , Subramaniam, Rathan M. , Romanoff, Justin , Sicks, JoRean D. , Bartel, Twyla B. , Chen, Chien , Lowe, Val J.

Otolaryngology–Head and Neck Surgery | November 24, 2020 | Volume: 164 | Issue: 6 | Pages: 1230-1239

10.1177/0194599820969104 Get It

ObjectiveFDG‐PET/CT (fluorodeoxyglucose–positron emission tomography/computed tomography) is effective to assess for occult neck nodal disease. We report risks and patterns of nodal disease based on primary site and nodal level from data on the dissected cN0 per the results from ACRIN 6685.Study DesignProspective nonrandomized enrollment included participants with first‐time head and neck squamous cell carcinoma and at least 1 cN0 neck side to be dissected.SettingTwenty‐four ACRIN‐certified centers internationally (American College of Radiology Imaging Network).MethodsA total of 287 participants were enrolled. Preoperative FDG‐PET/CT findings were centrally reviewed and compared with pathology. Incidence, relative risk, pattern of lymph node involvement, and impact upon neck dissection were reported.ResultsAn overall 983 nodal levels were dissected (n = 261 necks, n = 203 participants). The highest percentages of ipsilateral positive nodes by primary location and nodal level were oral cavity (level I, 17/110, 15.5%), pharynx (level II, 6/30, 20.0%), and larynx (level VI, 1/3, 33.3%).ConclusionLevels at greatest risk for nodal disease in cN0 in terms of ipsilateral neck dissection are level I (oral cavity), II (pharynx), and VI (larynx). These data should be considered when treating patients presenting with cN0. This is the first study to comprehensively report the incidence, location, and risk of metastases in cN0 in the FDG‐PET/CT era.